AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Infant Bacterial Therapeutics AB (publ)

SEK 65.70 +$15.90 (+31.93%)
STO · 30 Oct 2026 11:45 UTC
Previous Close
SEK 68.30
Day Range
SEK 65.10SEK 68.20
Year Range
SEK 43.25SEK 84.90
Market Cap
885.07M
AVG Volume
7.68K
Trailing/Forward PE
-10.79/2.67
PEG ratio
1.43
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Stockholm Stock ExchangeSE
Revenue (SEK) · TTM
-20K020K40K60K80K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IBT-B.ST Revenue (SEK) by quarter, trailing twelve months
PeriodRevenue (SEK)
26 Q20
26 Q10
25 Q40
25 Q3-1K
25 Q2-1K
25 Q1-1K
24 Q44K
24 Q35K
24 Q269K
24 Q169K
Net Income (SEK) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IBT-B.ST Net Income (SEK) by quarter, trailing twelve months
PeriodNet Income (SEK)
26 Q2-81.92M
26 Q1-71.36M
25 Q4-65.17M
25 Q3-79.73M
25 Q2-102.33M
25 Q1-125.83M
24 Q4-136.91M
24 Q3-144.03M
24 Q2-142.27M
24 Q1-128.41M
Operating Income (SEK) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IBT-B.ST Operating Income (SEK) by quarter, trailing twelve months
PeriodOperating Income (SEK)
26 Q2-85.11M
26 Q1-75M
25 Q4-68.99M
25 Q3-85.9M
25 Q2-108.89M
25 Q1-133.04M
24 Q4-145.34M
24 Q3-153.55M
24 Q2-153.45M
24 Q1-140.12M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (SEK) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: IBT-B.ST

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 13 Nov 2026.

Infant Bacterial Therapeutics AB (publ)
IBT-B.ST
Stockpicker

Video analysis: IBT-B.ST

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IBT-B.ST

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.